in , , , ,

Sanders Points Out Rising NASA Kleptocracy, Criticizes Elon Musk

In recent media interaction on the ‘Face the Nation’ broadcast from CBS, Sen. Bernie Sanders expressed his concerns over some notorious trends that have been shaping America’s political scene. He unveiled his apprehensions around the rising prominence of a ‘kleptocracy’, a form of governance where state funds are misused for individual gain by those in power. In these extraordinary times for America, Sanders pledged to rally his supporters to ensure an economy favourable to all citizens, rather than catering only to the rich and powerful individuals like Elon Musk.

Sen. Sanders used this platform not only to share his broader concerns about the socio-political climate, but also to voice his objections to certain influential corporations, including Elon Musk’s and Amazon. He criticized the Trump administration on grounds of strengthening business tycoons like Musk and Jeff Bezos at the cost of reducing the effectiveness of the National Labor Relations Board. Sanders seemed to express a strong displeasure at this development.

The degradation of the National Labor Relations Board, according to Sanders, was orchestrated to favour billionaires like Musk and Bezos. This, he speculated, enables corporations notorious for their union-busting tactics, such as Amazon, to continue compromising workers’ rights without fear of repercussions. Sanders, a staunch advocate for labour rights, was unreserved in his criticisms of this situation.

During the conversation, Sanders was probed about his stance on Robert F. Kennedy Jr.’s nomination for Secretary of Health and Human Services. The senator kept his cards close to his chest and did not directly state whether he would support Kennedy’s confirmation. However, he expressed dissatisfaction over Kennedy’s presentation and overall outlook.

Sanders pointed out his dissatisfaction with Kennedy’s indecisiveness concerning the pharmaceutical industry’s unchecked greed and the dire need to reduce prescription drug prices. His discomfort with Kennedy’s stance was apparent in the way he shared his perspectives. It was clear that Sanders had anticipated a more impactful response from Kennedy on these critical issues.

However, when questioned on whether he planned to vote in favor or against Kennedy’s appointment, the Vermont senator maintained ambiguity. Sanders’ silence on his voting intentions added a layer of suspense to the nomination process as he chose not to disclose his decision beforehand. His approach prompted much speculation about the potential outcomes of this nomination.